Metabolic tests to determine risk for type 1 diabetes in clinical trials.
about
Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploringFall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet dataThe acute and residual effect of a single exercise session on meal glucose tolerance in sedentary young adults.In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions.Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.Dysregulation of glucose metabolism in preclinical type 1 diabetes.
P2860
Metabolic tests to determine risk for type 1 diabetes in clinical trials.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Metabolic tests to determine risk for type 1 diabetes in clinical trials.
@ast
Metabolic tests to determine risk for type 1 diabetes in clinical trials.
@en
type
label
Metabolic tests to determine risk for type 1 diabetes in clinical trials.
@ast
Metabolic tests to determine risk for type 1 diabetes in clinical trials.
@en
prefLabel
Metabolic tests to determine risk for type 1 diabetes in clinical trials.
@ast
Metabolic tests to determine risk for type 1 diabetes in clinical trials.
@en
P2093
P2860
P356
P1476
Metabolic tests to determine risk for type 1 diabetes in clinical trials.
@en
P2093
B Buckingham
Carla J Greenbaum
Diabetes Prevention Trial, Type 1 Diabetes (DPT-1) Study Group
J Krischer
P2860
P304
P356
10.1002/DMRR.1205
P577
2011-09-01T00:00:00Z